Leerink Partners analyst Whit Mayo lowered the price target on Elevance (NYSE: ELV) to $515.00 (from $620.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Elevance (ELV) PT Lowered to $548 at JPMorganOctober 23, 2024 4:13 PM Form 4 Elevance Health, Inc. For: Oct 18 Filed by: Kendrick Charles Morgan JROctober 18, 2024 5:22 PM Form 144 Elevance Health, Inc. Filed by: Kendrick Charles Morgan JROctober 18, 2024 1:49 PM Argus Downgrades Elevance (ELV) to HoldOctober 18, 2024 7:30 AM Elevance (ELV) PT Lowered to $478 at RBC CapitalOctober 18, 2024 7:04 AM Elevance (ELV) PT Lowered to $520 at Truist SecuritiesOctober 18, 2024 6:59 AM Elevance (ELV) PT Lowered to $555 at UBSOctober 18, 2024 6:26 AM Increasing unusual put option volume: ELV LAC CNC MGNI FITB WEN EOSE EWW ASHR OKLOOctober 18, 2024 5:20 AM Form 10-Q Elevance Health, Inc. For: Sep 30October 17, 2024 5:02 PM U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.37%October 17, 2024 4:43 PM Form 8-K Elevance Health, Inc. For: Oct 17October 17, 2024 6:03 AM Elevance Health Inc. (ELV) Misses Q3 EPS by $1.29, Beats on RevenueOctober 17, 2024 6:01 AM Elevance Health Reports Third Quarter 2024 ResultsOctober 17, 2024 6:00 AM